These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 25624352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain.
    Maruta T, Dolimbek BZ, Aoki KR, Steward LE, Atassi MZ.
    Protein J; 2004 Nov; 23(8):539-52. PubMed ID: 15648976
    [Abstract] [Full Text] [Related]

  • 3. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
    Oshima M, Deitiker P, Jankovic J, Atassi MZ.
    Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721
    [Abstract] [Full Text] [Related]

  • 4. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
    Kroken AR, Blum FC, Zuverink M, Barbieri JT.
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Location of the synaptosome-binding regions on botulinum neurotoxin B.
    Dolimbek BZ, Steward LE, Aoki KR, Atassi MZ.
    Biochemistry; 2012 Jan 10; 51(1):316-28. PubMed ID: 22146011
    [Abstract] [Full Text] [Related]

  • 7. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
    Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ.
    Immunobiology; 2012 Jan 10; 217(1):17-27. PubMed ID: 21962573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains.
    Dolimbek GS, Dolimbek BZ, Aoki KR, Atassi MZ.
    Immunol Invest; 2005 Jan 10; 34(2):119-42. PubMed ID: 15921155
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE, Cai F, Neale EA.
    Biochemistry; 2004 Jan 20; 43(2):526-32. PubMed ID: 14717608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y, Singh BR.
    Protein Expr Purif; 2004 Mar 20; 34(1):8-16. PubMed ID: 14766296
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.